drugset / Trial / NCT01068964

Safety and Efficacy of Bimatoprost Timolol Ophthalmic Solution in Patients With Open Angle Glaucoma or Ocular Hypertension

NCT01068964

Completed 235 enrolled Allergan
RandomizedParallel-groupTriple-blindTreatment

Summary

This study will evaluate the safety and efficacy of once daily administered 0.03% Bimatoprost/0.5% Timolol Ophthalmic Solution compared with once daily administered 0.03% Bimatoprost Ophthalmic Solution and once daily administered 0.5% Timolol Ophthalmic Solution concurrently in patients with open-angle glaucoma or ocular hypertension

Timeline

Start
2010-02-01
Primary completion
2010-09-01
Completion
2010-09-01

Drugs

EvaluationDrugModalityDoseRoute
Subject 0.03% Bimatoprost/0.5% Timolol Ophthalmic Solution Unknown 0.03 % Other
Subject 0.03% Bimatoprost/0.5% Timolol Ophthalmic Solution Unknown 0.5 % Other
Comparator Bimatoprost Other / unclassified 0.03 % Other
Comparator Timolol Other / unclassified 0.5 % Other